Filing Flows

Filing Flows › Comparisons › HIMS vs STLN

Hims & Hers Health vs Starling Oncology: HIMS and STLN compared

Hims & Hers Health is the larger company: $753M of revenue in its latest quarter (Q2 2026) against $170M for Starling Oncology (Q3 2026). Hims & Hers Health is growing faster (+38% against +24% a year earlier). Starling Oncology is more profitable, with an operating margin of -1.8% against -12.9%.

Hims & Hers Health vs Starling Oncology, latest quarterHims & Hers Health vs Starling Oncology, latest quarterHims & Hers Health (HIMS)Starling Oncology (STLN)Revenue$753M$170MRevenue growth, Y/Y+38%+24%Operating margin-12.9%-1.8%Net margin-11.5%-9.3%

Where the money goes: HIMS and STLN

Hims & Hers Health (HIMS) · Q2 2026

Hims & Hers Health, Q2 2026: revenue $753M (+38% year over year), operating margin -12.9%, net loss $86.3M, operating cash flow −$35.9M. The chart follows the revenue to costs, profit and cash.

Starling Oncology (STLN) · Q3 2026

Starling Oncology, Q3 2026: revenue $170M (+24% year over year), operating margin -1.8%, net loss $15.7M, operating cash flow $10.1M. The chart follows the revenue to costs, profit and cash.

Starling Oncology revenue by segment, Q3 2026Starling Oncology revenue by segment, Q3 2026Specialty Pharmacy$109MPatient services$60.0M
Hims & Hers Health (HIMS)Starling Oncology (STLN)
Latest quarterQ2 2026Q3 2026
Revenue$753M$170M
Revenue growth, Y/Y+38%+24%
Operating margin-12.9%-1.8%
Net earnings−$86.3M−$15.7M
Net margin-11.5%-9.3%
Operating cash flow−$35.9M$10.1M
Free cash flow—$8.9M
Market value$6.0B—
Analysts’ mean target$31.15—

Where the revenue comes from

Starling Oncology

Questions

Which is bigger, Hims & Hers Health or Starling Oncology?

Hims & Hers Health is the larger company: $753M of revenue in its latest quarter (Q2 2026) against $170M for Starling Oncology (Q3 2026).

Is Hims & Hers Health or Starling Oncology growing faster?

Hims & Hers Health is growing faster (+38% against +24% a year earlier).

Which is more profitable, Hims & Hers Health or Starling Oncology?

Starling Oncology is more profitable, with an operating margin of -1.8% against -12.9%.

More: Hims & Hers Health earnings · how Hims & Hers Health makes money · Starling Oncology earnings · how Starling Oncology makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 10, 2026; 10-Q filed Nov 6, 2026). Fiscal quarters can end on different dates. Not investment advice.